CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$0.58
52W Range
$0.53 - $172.00
50D Avg
$1.25
200D Avg
$9.24
Market Cap
$1.81M
Avg Vol (3M)
$714.17K
Beta
0.73
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.